Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Mantovani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Developmental Medicine and Child Neurology|February 13, 2003
Not knowingJohn F Mantovani
Developmental Medicine and Child Neurology. Supplement|March 21, 2007
Definition and classification of CP: medical-legal and service implicationsJohn F Mantovani
Human Mutation|April 11, 2012
Splice site, frameshift, and chimeric GFAP mutations in Alexander diseaseDaniel Flint, Rong Li, Lital S Webster, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.
American Journal of Human Genetics|December 30, 2025
De novo variants in KDM2A cause a syndromic neurodevelopmental disorderEric N Anderson, Stephan Drukewitz, Sukhleen Kour, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
De novo variants in <i>KDM2A</i> cause a syndromic neurodevelopmental disorderEric N Anderson, Stephan Drukewitz, Sukhleen Kour, et al.
Brain : a Journal of Neurology|April 6, 2017
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disordersMarkus Wolff, Katrine M Johannesen, Ulrike B S Hedrich, et al.
American Journal of Human Genetics|August 2, 2020
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function EffectsAndreea Manole, Stephanie Efthymiou, Emer O'Connor, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Developmental Medicine and Child Neurology|February 13, 2003
Not knowingJohn F Mantovani
Developmental Medicine and Child Neurology. Supplement|March 21, 2007
Definition and classification of CP: medical-legal and service implicationsJohn F Mantovani
Human Mutation|April 11, 2012
Splice site, frameshift, and chimeric GFAP mutations in Alexander diseaseDaniel Flint, Rong Li, Lital S Webster, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.
American Journal of Human Genetics|December 30, 2025
De novo variants in KDM2A cause a syndromic neurodevelopmental disorderEric N Anderson, Stephan Drukewitz, Sukhleen Kour, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
De novo variants in <i>KDM2A</i> cause a syndromic neurodevelopmental disorderEric N Anderson, Stephan Drukewitz, Sukhleen Kour, et al.
Brain : a Journal of Neurology|April 6, 2017
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disordersMarkus Wolff, Katrine M Johannesen, Ulrike B S Hedrich, et al.
American Journal of Human Genetics|August 2, 2020
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function EffectsAndreea Manole, Stephanie Efthymiou, Emer O'Connor, et al.
Pageof 1